Bipin N Savani

Bipin N Savani

UNVERIFIED PROFILE

Are you Bipin N Savani?   Register this Author

Register author
Bipin N Savani

Bipin N Savani

Publications by authors named "Bipin N Savani"

Are you Bipin N Savani?   Register this Author

98Publications

1432Reads

19Profile Views

CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.

Bone Marrow Transplant 2020 Aug 18;55(8):1525-1532. Epub 2020 Apr 18.

The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0892-7DOI Listing
August 2020

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.

Biol Blood Marrow Transplant 2020 Jul 9;26(7):1247-1256. Epub 2020 Mar 9.

BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.002DOI Listing
July 2020

Graft-versus-host-disease does not help acute lymphoblastic leukaemia patients with measurable residual disease.

Br J Haematol 2020 Jul 17;190(1):22-23. Epub 2020 Mar 17.

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16570DOI Listing
July 2020

Securing the graft during pandemic: are we ready for cryopreservation for all?

Biol Blood Marrow Transplant 2020 Jul 17;26(7):e145-e146. Epub 2020 Apr 17.

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162777PMC
July 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Prognostic scoring system after transplantation in myeloma: predicting early relapse.

Br J Haematol 2020 Jul 26. Epub 2020 Jul 26.

Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16986DOI Listing
July 2020

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.

Bone Marrow Transplant 2020 Jun 28;55(6):1137-1146. Epub 2020 Jan 28.

Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0791-yDOI Listing
June 2020

Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease.

Blood Rev 2020 Jun 6:100719. Epub 2020 Jun 6.

The Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100719DOI Listing
June 2020

A stitch in time saves nine… MRD-based pre-emptive therapy.

Br J Haematol 2020 Jun 30. Epub 2020 Jun 30.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16913DOI Listing
June 2020

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2020 May 26;105(5):1329-1338. Epub 2019 Sep 26.

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193485PMC
May 2020

Allogeneic haematopoietic cell transplantation after CAR T-cell therapy: safe, effective and contentious.

Br J Haematol 2020 Apr 8;189(1):21-23. Epub 2019 Nov 8.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16262DOI Listing
April 2020

How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?

Br J Haematol 2020 Apr 16;189(2):239-240. Epub 2020 Mar 16.

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161755PMC
April 2020

Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

Bone Marrow Transplant 2020 Mar 21;55(3):505-522. Epub 2019 Aug 21.

Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0643-9DOI Listing
March 2020

Who is the best relative? Optimizing haploidentical donor transplantation in lymphoma.

Br J Haematol 2020 Mar 2;188(5):601-602. Epub 2019 Sep 2.

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16178DOI Listing
March 2020

Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives.

Blood Rev 2020 Feb 26:100674. Epub 2020 Feb 26.

Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100674DOI Listing
February 2020

Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis.

Cancer 2019 Dec 23;125(24):4417-4425. Epub 2019 Aug 23.

Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32464DOI Listing
December 2019

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.

Leukemia 2019 12 5;33(12):2767-2778. Epub 2019 Nov 5.

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0615-5DOI Listing
December 2019

Transgender individuals represent an overlooked population amongst stem cell donors.

Bone Marrow Transplant 2019 11 18;54(11):1721-1722. Epub 2019 Jan 18.

Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0437-0DOI Listing
November 2019

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

Biol Blood Marrow Transplant 2019 06 15;25(6):e191-e198. Epub 2019 Jan 15.

Physical Therapy Association for Graft Versus Host Disease, Swindon, United Kingdom; Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193006
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.01.018DOI Listing
June 2019

ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 03 25;25(3):e86-e88. Epub 2018 Dec 25.

Adult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183162
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.757DOI Listing
March 2019

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2018 11 7;24(11):2224-2232. Epub 2018 Aug 7.

Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Tel Aviv University, Tel-Aviv, Israel; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.07.007DOI Listing
November 2018

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Biol Blood Marrow Transplant 2018 10 9;24(10):2081-2087. Epub 2018 May 9.

Division of Infectious Diseases, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.031DOI Listing
October 2018

Leukaemia risk associated with low-dose radiation.

Lancet Haematol 2018 08 17;5(8):e324-e325. Epub 2018 Jul 17.

Hematology and Stem Cell Transplantation Section, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30106-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097528PMC
August 2018